Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32+0.00 (+1.30%)
Close on Nov 18, 2026Market cap $11.66MP/E –Yield –
Dyadic International cash
Cash and short-term investments held at the end of each period.
Dyadic International's cash was $6.00M at Sep 30, 2026. For fiscal 2025 it was $8.60M, down 7.5% from the year before. The highest annual figure on record is $20.64M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.60M | -7.5% |
| FY2024 | Dec 31, 2024 | $9.30M | +27.4% |
| FY2023 | Dec 31, 2023 | $7.30M | +26.0% |
| FY2022 | Dec 31, 2022 | $5.79M | -63.2% |
| FY2021 | Dec 31, 2021 | $15.75M | -23.7% |
| FY2020 | Dec 31, 2020 | $20.64M | +327.8% |
| FY2019 | Dec 31, 2019 | $4.82M | +102.1% |
| FY2018 | Dec 31, 2018 | $2.39M | -58.8% |
| FY2017 | Dec 31, 2017 | $5.79M | -59.4% |
| FY2016 | Dec 31, 2016 | $14.25M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.00M | -42.3% |
| Q2 FY2026 | Jun 30, 2026 | $4.80M | -34.2% |
| Q1 FY2026 | Mar 31, 2026 | $6.60M | -10.2% |
| Q4 FY2025 | Dec 31, 2025 | $8.60M | -7.5% |
| Q3 FY2025 | Sep 30, 2025 | $10.40M | +75.6% |
| Q2 FY2025 | Jun 30, 2025 | $7.30M | +19.0% |
| Q1 FY2025 | Mar 31, 2025 | $7.35M | -30.5% |
| Q4 FY2024 | Dec 31, 2024 | $9.30M | +27.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.92M | -20.0% |
| Q2 FY2024 | Jun 30, 2024 | $6.13M | +5.0% |
| Q1 FY2024 | Mar 31, 2024 | $10.57M | +65.8% |
| Q4 FY2023 | Dec 31, 2023 | $7.30M | +26.0% |
| Q3 FY2023 | Sep 30, 2023 | $7.40M | +9.9% |
| Q2 FY2023 | Jun 30, 2023 | $5.84M | -38.4% |
| Q1 FY2023 | Mar 31, 2023 | $6.37M | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | $5.79M | -63.2% |
| Q3 FY2022 | Sep 30, 2022 | $6.74M | -50.7% |
| Q2 FY2022 | Jun 30, 2022 | $9.48M | -32.4% |
| Q1 FY2022 | Mar 31, 2022 | $12.42B | +95024.5% |
| Q4 FY2021 | Dec 31, 2021 | $15.75M | -23.7% |
| Q3 FY2021 | Sep 30, 2021 | $13.66M | -37.5% |
| Q2 FY2021 | Jun 30, 2021 | $14.02M | +19.0% |
| Q1 FY2021 | Mar 31, 2021 | $13.06M | +178.0% |
| Q4 FY2020 | Dec 31, 2020 | $20.64M | +327.8% |
| Q3 FY2020 | Sep 30, 2020 | $21.86M | +368.9% |
| Q2 FY2020 | Jun 30, 2020 | $11.78M | +146.4% |
| Q1 FY2020 | Mar 31, 2020 | $4.70M | +18.1% |
| Q4 FY2019 | Dec 31, 2019 | $4.82M | +102.1% |
| Q3 FY2019 | Sep 30, 2019 | $4.66M | +171.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.78M | +48.5% |
| Q1 FY2019 | Mar 31, 2019 | $3.98M | -14.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.39M | -58.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.71M | -88.0% |
| Q2 FY2018 | Jun 30, 2018 | $3.22M | – |
| Q1 FY2018 | Mar 31, 2018 | $4.63M | – |
| Q4 FY2017 | Dec 31, 2017 | $5.79M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.25M | – |
See a number that looks wrong?